Clinical Trial

ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS

Name: ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS — clinical trial record (NCT07371689)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ANAPEM

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Double blind RCT aiming to compare the efficacy of Anakinra vs placebo, on top of the standard of care, on restoration of myocardial function at 3 days following treatment initiation, in children admitted for acute myocarditis in intensive care units.

Trial Details

NCT Number	NCT07371689
Lead Sponsor	Assistance Publique - Hôpitaux de Paris
Conditions	PEDIATRIC ACUTE MYOCARDITIS
Enrollment	110 participants
Start Date	2026-02
Primary Completion	2029-12 (estimated)
Study Completion	2029-12 (estimated)
Updated on ClinicalTrials.gov	2026-01-28